<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0000819'>Diabetes mellitus</z:hpo> is increasing among young adult South Asians </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to determine the prevalence and phenotypic characteristics of <z:mp ids='MP_0002055'>diabetes</z:mp> subtypes based on GAD65 autoantibody (GADA) status in those with <z:hpo ids='HP_0011462'>young adult-onset</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp> in Sri Lanka </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Clinical, metabolic and GADA data were available for 992 consecutively recruited individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> aged &lt; or =45 years (age at diagnosis 16-40 years) </plain></SENT>
<SENT sid="3" pm="."><plain>Participants were classified according to the following definitions: type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, insulin-dependent &lt;6 months from diagnosis; latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> in adults (LADA), GADA-positive, age &gt; or =30 years and insulin-independent &gt; or =6 months from diagnosis; type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, GADA-negative and insulin-independent &gt; or =6 months from diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The median (interquartile range) age at diagnosis and <z:mp ids='MP_0002055'>diabetes</z:mp> duration were 33.0 (29.0-36.1) and 4.0 (1.1-7.1) years, respectively; 42.1% were male </plain></SENT>
<SENT sid="5" pm="."><plain>GADA positivity was seen in 5.4% of participants (n = 54) and GADA levels negatively correlated with age at diagnosis (p &lt; 0.0001), BMI (p &lt; 0.0001) and time to insulin requirement (p = 0.006) </plain></SENT>
<SENT sid="6" pm="."><plain>Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and LADA were present in 7.0%, 89.7% and 2.6%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The remaining 0.7% of the participants were GADA-positive, insulin independent &gt; or =6 months from diagnosis and were diagnosed at age &lt;30 years </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and homeostasis model assessment of beta cell function (HOMA %B) were lowest in GADA-positive type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and increased progressively in latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp>, GADA-negative type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Among those requiring insulin, 69.2% had fasting C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels in the lowest quartile, whereas only 19.5% were GADA-positive (p &lt; 0.0001) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: The prevalence of GADA-positive autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> is low among individuals with <z:hpo ids='HP_0011462'>young adult-onset</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp> in Sri Lanka </plain></SENT>
<SENT sid="11" pm="."><plain>Young-<z:hpo ids='HP_0003674'>onset</z:hpo> diabetic phenotypes appear as a continuum from autoimmune type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>